You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COVID vaccine booster

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial (SARS-CoV-2 Subunit Recombinant Protein Vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 Subunit Recombinant Protein Vaccine
  • (no location specified)
Jul 5, 2023

COVID-19 Trial (1 Nebulized inhalation for booster groups, 2 Nebulized inhalation for booster groups, 3 Nebulized inhalation for

Recruiting
  • COVID-19
  • 1 Nebulized inhalation for booster groups
  • +23 more
  • Xiangxi, Hunan, China
    CDC of of Luxi County, Xiangxi Tujia and Miao Autonomous Prefect
Oct 24, 2022

COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
  • Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
  • (no location specified)
Jun 19, 2023

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant

Not yet recruiting
  • COVID-19
  • High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
  • +3 more
  • (no location specified)
Jun 19, 2023

Oxford-AstraZeneca COVID-19 Vaccine as2nd Booster,

Recruiting
  • COVID-19
  • ChAdOx1 nCOV-19 vaccine (Vaxzeria)
  • +3 more
  • São Paulo, Brazil
    Techtrials Pesquisa e Tecnologia Ltda.
Jan 23, 2023

Moderna COVID-19 Bivalent Booster for Omicron BA.4/5

Recruiting
  • COVID-19
  • Moderna COVID-19 Vaccine
  • +3 more
  • Culver City, California
    Science37
Mar 9, 2023

COVID-19 Trial in Nanjing (Intramuscularly administered Ad5-nCoV vaccine, Aerosolized Ad5-nCoV, DelNS1-2019-nCoV-RBD-OPT1)

Not yet recruiting
  • COVID-19
  • Intramuscularly administered Ad5-nCoV vaccine
  • +3 more
  • Nanjing, Jiangsu, China
    Jiangsu Provincial Center for Disease Control and Prevention
May 10, 2023

COVID-19 Trial (Invitation to get a 2nd booster dose of COVID-19 vaccine)

Not yet recruiting
  • COVID-19
  • Invitation to get a 2nd booster dose of COVID-19 vaccine
  • (no location specified)
Sep 14, 2022

COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

Not yet recruiting
  • COVID-19 Vaccine
  • COVID-19
  • 50 μg Baiya SARS-CoV-2 Vax 2
  • Placebo
  • Bangkok, Thailand
    Queen Saovabha Memorial Institute
May 23, 2023

COVID-19 Pandemic, COVID-19 Vaccines Trial in Surabaya (Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg,

Recruiting
  • COVID-19 Pandemic
  • COVID-19 Vaccines
  • Vaksin Merah Putih - UA SARS-CoV-2 (Vero Cell Inactivated) 5 µg
  • CoronaVac Biofarma COVID-1 9 Vaccine 3 µg
  • Surabaya, East Java, Indonesia
    Dr. Soetomo General Hospital
Jun 21, 2023

Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

Not yet recruiting
  • Immunogenicity
  • Safety
  • Phase II:SWIM816;SARS-Cov-2;
  • +3 more
  • (no location specified)
Jun 18, 2023

COVID-19 Trial in Chengdu (LYB002V14, LYB002V14A, LYB002CA)

Active, not recruiting
  • COVID-19
  • LYB002V14
  • +2 more
  • Chengdu, Sichuan, China
    Affiliated Hospital of North Sichuan MedicalCollege
Jun 29, 2023

COVID-19, Vaccine Reaction Trial in Chengdu (LYB001, CoronaVac)

Active, not recruiting
  • COVID-19
  • Vaccine Reaction
  • LYB001
  • CoronaVac
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital Affiliated to North Sichuan Medical Coll
Jun 29, 2023

COVID-19 Trial in Kunming (RQ3013, RQ3025, RQ3027)

Recruiting
  • COVID-19
  • RQ3013
  • +2 more
  • Kunming, Yunnan, China
    The Affiliated Hospital of Yunnan University
Jun 22, 2023

COVID-19 Trial in Bandung (SARS-CoV-2 subunit protein recombinant vaccine)

Not yet recruiting
  • COVID-19
  • SARS-CoV-2 subunit protein recombinant vaccine
  • Bandung, Jawa Barat, Indonesia
    Faculty of Medicine Universitas Padjadjaran
Feb 13, 2023

COVID-19 Respiratory Infection, COVID-19 Vaccine Adverse Reaction Trial in Stockholm (DNA vaccine OC-007, Placebo)

Not yet recruiting
  • COVID-19 Respiratory Infection
  • COVID-19 Vaccine Adverse Reaction
  • DNA vaccine OC-007
  • Placebo
  • Stockholm, Region Stockholm, Sweden
    Phase I Study Unit, Karolinska University Hospital
Jan 13, 2023

Humoral Immunity Trial in Gomel (Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by

Enrolling by invitation
  • Humoral Immunity
  • Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)
  • Gomel, Belarus
    Gomel State Medical University
Jan 30, 2023

COVID-19 Trial in Paris (Lymph node aspiration / Blood sampling)

Recruiting
  • COVID-19
  • Lymph node aspiration / Blood sampling
  • Paris, France
    GH Broca-Cochin-Hôtel-Dieu CIC 1417 Cochin-Pasteur
Jul 19, 2023

COVID-19 Trial in Natal, São Paulo (SCB-2019/Clover, AstraZeneca/Fiocruz, Pfizer/Wyeth)

Active, not recruiting
  • COVID-19
  • SCB-2019/Clover
  • +2 more
  • Natal, Rio Grande Do Norte, Brazil
  • +1 more
Apr 10, 2023

Vaccine Reaction, COVID-19 Trial in Paris (Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech), VidPrevtyn® Beta

Not yet recruiting
  • Vaccine Reaction
  • COVID-19
  • Comirnaty® BNT162b2 /Omicron BA.4-5 vaccine (Pfizer-BioNTech)
  • VidPrevtyn® Beta vaccine (Sanofi/GSK)
  • Paris, France
    CIC 1417 Cochin-Pasteur
Feb 28, 2023

COVID-19 Trial in Huai'an (COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant), COVID-19 Vaccine (Vero cell),

Recruiting
  • COVID-19
  • COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
  • COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
  • Huai'an, Jiangsu, China
    Huaiyin Center for Disease Control and Prevention
Jan 11, 2023

COVID-19 Infection, COVID-19 Vaccine Adverse Reaction Trial in Seoul (LEM-mR203, Placebo)

Not yet recruiting
  • COVID-19 Infection
  • COVID-19 Vaccine Adverse Reaction
  • LEM-mR203
  • Placebo
  • Seoul, Korea, Republic of
    Seoul National University Hospital Clinical Trials Center
Sep 12, 2023

Inactivated COVID-19 Vaccine of the First Booster Dose

Active, not recruiting
  • COVID-19
  • COVID-19 Vaccine (Vero Cell), Inactivated
  • Manguinhos, Brazil
    Instituto Nacional de Infectologia Evandro Chagas (INI-FIOCRUZ)
Jan 11, 2023

COVID-19 Trial in United States (Vaccine Messaging, Vaccine Acceptance Question)

Not yet recruiting
  • COVID-19
  • Vaccine Messaging
  • Vaccine Acceptance Question
  • San Francisco, California
  • +6 more
Dec 1, 2023